Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
KY-19382 (Wnt/β-Catenin Follicle Pathway) research product
Shipping batchKY01View certificate

Follicle Research

KY-19382 (Wnt/β-Catenin Follicle Pathway)

KY-19382, also written KY19382, is a small molecule studied in Wnt/beta-catenin signaling and hair follicle models. This listing is a liquid research solution labeled 5 mg/mL in a 30 mL bottle.

In stock · ready to shipEarn 199 points
Quantity
1
$199.99
Save 10% with code WELCOME10 at checkout
Your purchasing batch
KY01
Certificate on record for this lot

Bundle & save

COA
Referral program · researchers save 10%, you earn 15% back
FedEx 2-Day shipping
Free on orders over $250
Ships from the US West Coast
Tracked delivery on every order
Per-batch COA access
Every order ships with certificate access for its lot
Secure encrypted checkout CASH APP 5% OFFZELLE 5% OFFBANK TRANSFER 5% OFFCHIME 5% OFFCRYPTO 7% OFFVISA · AMEX NO FEE

More ways to save

Up to20%OFF

Bulk Orders 20+ bottles

Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.

Ask about bulk

Shipping batch KY01

Open the certificate matched to this shipping batch.

View certificate ↗

Verified test results

Every batch, independently verified.

Each batch is analyzed by ILS Laboratories, an independent ISO/IEC 17025 accredited lab, before release. Below is the report for lot KY01, summarized from the certificate the lab published.

ILS
ILS Laboratories
Independent · ISO/IEC 17025 accredited
PASS
Certificate of Analysis · COA-2026-5J8TU3
Lot
KY01
Tested
Nov 4, 2026
Labeled
5mg (as reported)
ISO 17025 accreditedFentanyl freeFull QC panel
MethodFull QC Panel - supplied page 1 of 2
VerifyQR code and access code printed on the certificate
KY-19382 (Wnt/β-Catenin Follicle Pathway) certificate of analysisOpen the KY01 certificate
View the signed certificate →
Full QC Panel✓ 2 passed · 1 reported
Identity
HPLC-RTM
Confirmed
KY-19382
PASS
Net content
Per certificate
5.24mg
REPORT ONLY; report does not specify per mL
REPORTED
Fentanyl screen
Immunoassay
Not Detected
50 ng/mL cutoff
PASS

Every batch on record

This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.

Open the COA portal →

Side by side

How Disguised compares.

Disguised
Typical supplier
Per-batch third-party COA
Yes
Rarely provided
ISO 17025 lab testing
Yes
Inconsistent
HPLC purity verified
Yes
Often unverified
Conformity testing
Yes
Not standard
Fentanyl screening
Yes
Not standard
Made & tested in the USA
Yes
Often overseas
Discreet, tracked shipping
Yes
Varies

Technical specifications

Compound Information

Read the KY-19382 (Wnt/β-Catenin Follicle Pathway) research guide
Storage Requirements

Stability information.

Do not freezeProtect from lightClose after use
15–25°C
As shipped
Store at room temperature with the cap closed, away from direct light and heat.

Important research notice

Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.

All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.

By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.

Ready when you are

Nothing ships without paperwork. Every lot is on record.

The lot on this page links to the signed certificate for that batch.

1Lot on record
17025ISO/IEC accredited lab
Loading...
✓
View Full Product Description
Made in USAManufacturing originGMP CertifiedManufacturing standard

Liquid research preparation

KY-19382 (Wnt/β-Catenin Follicle Pathway): product details and research reference

KY-19382, also written KY19382, is a small molecule studied in Wnt/beta-catenin signaling and hair follicle models. This listing is a liquid research solution labeled 5 mg/mL in a 30 mL bottle.

Product specifications

CompoundKY-19382 (KY19382)
Labeled concentration5 mg/mL
Bottle volume30 mL
Calculated labeled total150 mg
FormatLiquid research solution

What is KY-19382?

KY-19382 is an indirubin-derived small molecule. Research has investigated its effects on Wnt/beta-catenin signaling through CXXC5-Dishevelled interaction and GSK-3 beta inhibition.

Is KY-19382 a peptide?

No. KY-19382 is a small molecule, although it can appear alongside peptides in a research catalog. Use the full compound identity when selecting literature and analytical methods.

What evidence supports the follicle research context?

Ryu and colleagues studied human dermal papilla cells, cultured follicles and mouse models. Those preclinical systems provide mechanistic evidence; they do not establish a human hair-growth claim for this research solution.

Is KY-19382 the same as RU58841?

No. KY-19382 is associated with Wnt signaling research. RU58841 is studied as an androgen receptor antagonist. The RU58841 and Minoxidil blend is also a different formulation with two components.

Research sources

Ryu et al., 2021: KY19382 preclinical follicle study. See the KY19382 evidence guide and Follicle Research collection.

Selected research and evidence

Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.

  1. KY19382 in Wnt and hair-follicle modelsCells, cultured follicles and mouse research · 2021 · PMID 33751552

    Studied Wnt/beta-catenin signaling and follicle responses. The study does not demonstrate a clinical outcome from this research solution.

Documentation and research handling

Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.

Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.

Product questions

How do concentration and total content differ?

Concentration is the stated amount per mL; total content also depends on the container volume. A per-spray amount requires a verified pump output and must not be inferred from concentration alone. Check each component separately for a blend.

Where is the batch-specific evidence?

Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.

Do these studies test this finished product?

The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.

Questions about KY-19382

What is KY-19382?

A synthetic small molecule, not a peptide: 5,6-dichloroindirubin-3′-methoxime, written KY19382 in papers, C₁₇H₁₁Cl₂N₃O₂ at 360.2 g/mol in PubChem. In a 2019 paper, a Yonsei University group in Seoul reported selecting it from 60 newly synthesized indirubin derivatives tested against the CXXC5-Dishevelled interaction and GSK-3β kinase activity.

How does KY-19382 work?

Through two actions its developers measured in cell-free assays: it blocked CXXC5, a negative regulator of Wnt/β-catenin signaling, from binding Dishevelled (IC50 19 nM) and inhibited the kinase GSK-3β (IC50 10 nM); in mouse ATDC5 chondrogenic cells it raised β-catenin. In human cutaneous squamous cell carcinoma cells, by contrast, it inhibited Wnt/β-catenin signaling.

What has KY-19382 been studied in?

All preclinical. Across the 11 PubMed records that name KY19382 (searched 15 October 2026), the models are cell-free assays, human dermal papilla, skin and endothelial cells, cancer cell lines, a mouse chondrogenic cell line, cultured hair follicles, formulation tests, and mouse hair-follicle, wound, growth-plate and skin-tumor models. None reports giving it to people; Drugs@FDA lists no KY19382 product.

Where can I buy KY-19382 for research?

This page lists KY-19382 as a liquid research solution supplied at 5MG/ML in a 30ML bottle, providing 150MG total KY-19382 content. It is sold exclusively for laboratory research purposes, not for human, veterinary, or food use, and ships from the US West Coast, by FedEx 2-Day shipping.

View Currently Shipping CoA

The current certificate is matched to the selected product option and assigned shipping batch.

Enable JavaScript to view the certificate for your selected option.